CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-15 | Megna Michael R Chief Accounting Officer | Grant or award | +588 | $11.49 | $7K | 2,771 |
| 2021-07-15 | Moat Ross Chief Commercial Officer | Grant or award | +963 | $11.49 | $11K | 4,345 |
| 2021-07-15 | Tessari Eben Chief Operating Officer | Grant or award | +868 | $11.49 | $10K | 106,810 |
| 2021-06-29 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Share Option (right to buy) | +66,474 | 66,474 | ||
| 2021-06-29 | McCain Tracey L Director | Grant or award · Share Option | +33,237 | 33,237 | ||
| 2021-06-29 | Popovits Kimberly J Director | Grant or award · Share Option | +33,237 | 33,237 | ||
| 2021-06-29 | Malley Thomas Director | Grant or award · Share Option | +33,237 | 33,237 | ||
| 2021-06-29 | Quart Barry D Director | Grant or award · Share Option | +33,237 | 33,237 | ||
| 2021-06-29 | Levy Richard S Director | Grant or award · Share Option | +33,237 | 33,237 | ||
| 2021-06-29 | Cole G Bradley Director | Grant or award · Share Option | +33,237 | 33,237 | ||
| 2021-04-26 | Ragosa Mark CFO | Grant or award · Share Option | +23,725 | 23,725 | ||
| 2021-04-26 | Ragosa Mark CFO | Grant or award · Restricted Share Units | +3,962 | 3,962 | ||
| 2021-03-20 | Ragosa Mark CFO | Grant or award · Restricted Share Units | +3,019 | 3,019 | ||
| 2021-03-20 | Ragosa Mark CFO | Grant or award · Restricted Share Units | +2,158 | 2,158 | ||
| 2021-03-20 | Paolini John F. SVP & Chief Medical Officer | Grant or award · Restricted Share Units | +5,676 | 5,676 | ||
| 2021-03-20 | Paolini John F. SVP & Chief Medical Officer | Grant or award · Restricted Share Units | +3,671 | 3,671 | ||
| 2021-03-20 | Megna Michael R Chief Accounting Officer | Grant or award · Restricted Share Units | +3,231 | 3,231 | ||
| 2021-03-20 | Megna Michael R Chief Accounting Officer | Grant or award · Restricted Share Units | +2,163 | 2,163 | ||
| 2021-03-20 | Patel Sanj K Chairman & CEO | Grant or award · Restricted Share Units | +18,555 | 18,555 | ||
| 2021-03-20 | Patel Sanj K Chairman & CEO | Grant or award · Restricted Share Units | +12,002 | 12,002 |
Page 71 of 74 · 1,467 trades